Lavie Bio Ltd. announced Amit Noam to be their CEO effective April 16, 2023, according to a release. Lavie Bio is an ag-biologicals company with a focus on food quality improvement, sustainability and agricultural productivity through microbiome-based products.
Noam has experience as a senior executive, specifically in the agriculture and healthcare areas. He has lead teams strategically to drive growth and value for businesses. Noam has been at AgriTask as their COO since 2018. AgriTask is an ag-tech company and during his time there, Noam lead commercial and operational strategies. Noam’s experience also include time at Teva Pharmaceuticals, Shaldor and Themis UAV.
Noam received his BSc in Industrial and Management Engineering from Ben-Gurion University in Beer Sheva, Israel and later an MBR from Tel Aviv University.
“I have a passion for technological innovation that positively impacts society, said Noam. “I strongly believe in Lavie Bio’s vision of improving food quality, agricultural sustainability, and productivity through ag-biological products, built using Evogene’s strong underlying AI tech-engines. Furthermore, Lavie Bio has a string of impressive achievements, as well as world leading partners and investors supporting it, namely Corteva and ICL Group. I am honored to have been given this opportunity to assume the CEO position of Lavie Bio, and I am excited to be joining the company at this key juncture in its development.”
“We are delighted to welcome Amit to the Evogene Group, to assume the leadership of Lavie Bio,” said Ofer Haviv, Lavie Bio chairperson & Evogene’s president and CEO. “Amit has a strong track record in leading early-stage companies through their commercial development stages, and I believe he is the right candidate to lead Lavie Bio.”
